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MaBACKGROUND The relationship between features of vulnerable plaque and angiographic coronary stenosis is unknown.
OBJECTIVES The purpose of this study was to systematically investigate the absolute number, relative prevalence, and
characteristics of thin-cap ﬁbroatheroma (TCFA) at different degrees of stenosis using optical coherence tomography
(OCT), intravascular ultrasound, and coronary angiography.
METHODS We identiﬁed 643 plaques from 255 subjects who underwent OCT imaging in all 3 coronary arteries. They
were divided into 3 groups on the basis of angiographic diameter stenosis: Group A (30% to 49%, n ¼ 325), Group B
(50% to 69%, n ¼ 227), and Group C (>70%, n ¼ 91).
RESULTS OCT showed that the absolute number of TCFA was greatest in Group A (n¼ 58), followed by Groups B (n¼ 40)
and C (n¼ 33). However, the relative prevalence of TCFAwas higher in Group C (36%) than in Groups A (18%) or B (18%) (p¼
0.003 and p¼0.002, respectively). Fibrous cap of TCFAwas thinner inGroupC than inGroups A (p<0.001) or B (p¼0.001).
intravascular ultrasound showed that the plaque burden of TCFAwas largest in Group C (80.1 7.4%), comparedwith Groups
B (67.5  9.4%) and A (58.1  8.4%). TCFA in Group C had a higher remodeling index than those in Group A (p ¼ 0.002).
CONCLUSIONS The absolute number of TCFA is 3 times greater in nonsevere stenosis than in severe stenosis. It is,
however, twice as likely for a lesion to be TCFA in cases of severe stenosis than in nonsevere stenosis. Moreover, TCFA
in severely-stenotic areas had more features of plaque vulnerability. (J Am Coll Cardiol 2014;64:672–80) © 2014 by the
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673AB BR E V I A T I O N S
AND ACRONYM S
ACS = acute coronary
syndromes
CSA = cross-sectional area
EEM = external elastic
membrane
IVUS = intravascular
ultrasound
OCT = optical coherence
tomography
TCFA = thin-cap ﬁbroatheromaT hin-cap ﬁbroatheroma (TCFA) is recognizedas a precursor for plaque rupture, which isresponsible for the majority of cases of acute
coronary syndromes (ACS) and sudden cardiac death.
Pathologically, TCFA is characterized as a large lipid
pool with overlying thin ﬁbrous cap (<65 mm) (1).
Clinical investigations have shown that TCFA is a
signiﬁcant predictor for rapid progression of angio-
graphic stenosis (2) and a strong predictor for future
clinical adverse events (3,4). Coronary angiogram
is routinely used to make a diagnosis of coronary
artery disease and to determine the extent of
luminal compromise. It had been widely believed
that vulnerable plaque is most often present in
areas of mild luminal stenosis (5). However, the abso-
lute number and relative prevalence of TCFA in rela-
tion to angiographic stenosis severity has not been
reported.SEE PAGE 681Intracoronary optical coherence tomography (OCT)
is a novel intracoronary diagnostic technique that
offers a resolution of approximately 10 to 20 mm. It
has the capability to measure the ﬁbrous cap thick-
ness and to detect lipid content, and can therefore
be used to identify in vivo TCFA and to determine
the plaque vulnerability (6). In the clinical setting,
intravascular ultrasound (IVUS) is another imaging
modality that has been used to measure lumen area,
plaque burden, and vascular remodeling (3,7). IVUS-
derived parameters, including plaque burden and
positive remodeling, are important for identiﬁcation
of high-risk TCFA during follow-up (3,4). However,
the relationship between OCT- and IVUS-derived
characteristics of TCFA, as well as the angiographic
stenosis severity, has not been reported.
In this study, we aimed to systematically investi-
gate the relationship between the absolute number
and relative prevalence and characteristics of TCFA,
as well as the angiographic stenosis severity, using
OCT, IVUS, and coronary angiography. In particular,
we were interested in testing the hypothesis that
vulnerable plaque characteristics were most fre-
quently associated with mild coronary artery lesions
as opposed to severe lesions.
METHODS
STUDY POPULATION. We identiﬁed patients who
underwent 3-vessel OCT examinations from the
Massachusetts General Hospital (MGH) OCT registry
and the 2nd Afﬁliated Hospital of Harbin Medical
University. All nonculprit or nontarget lesions with
>30% diameter stenosis on coronary angiogramswere chosen. Three-vessel OCT examinations
were performed in all 255 patients, whereas
IVUS was only performed in 143 patients. The
institutional review board in each partici-
pating site of the MGH registry and the ethics
committee of the 2nd Afﬁliated Hospital of
Harbin Medical University approved the
study, and all subjects provided informed
consent. Images were digitally stored and
submitted for offline evaluation at the core
laboratory.
ANGIOGRAM AND ANALYSIS. Patients were
pre-treated with aspirin ($300 mg) and clopidogrel
(300 mg) at least 2 h prior to the index procedure.
Coronary angiography was performed via the radial or
femoral approach using 6- to 7-F guiding catheters
after intracoronary administration of 100 to 200 mg
of nitroglycerin. Angiographic images were analyzed
using a quantitative coronary angiogram analysis
program (CAAS version 5.10.1, Pie Medical Imaging BV,
Maastricht, the Netherlands) by 2 investigators who
were blinded to the OCT and IVUS measurements.
Minimal luminal diameter was deﬁned as the smallest
lumen diameter in the segment of a lesion; reference
vessel diameter was calculated as the averaged diam-
eter of the proximal and distal coronary segments
without obvious narrowing; diameter stenosis was
calculated as: (reference vessel diameter  minimum
lumen diameter)/(reference vessel diameter)  100.
IVUS AND OCT EXAMINATIONS. After treatment of
the culprit/target lesion, IVUS and OCT imaging were
performed in all 3 coronary arteries. IVUS examina-
tions were performed using the Atlantis Pro catheter
(40 MHz, Boston Scientiﬁc, Natick, Massachusetts)
after intracoronary administration of 100 to 200 mg
nitroglycerin. The transducer was pulled back auto-
matically at 0.5 mm/s. After the IVUS examination,
OCT examinations were performed as previously
described (8,9). Either the time-domain (M2/M3 Car-
diology Imaging System, LightLab Imaging, Inc.,
Westford, Massachusetts) or the frequency-domain
OCT system (C7-XR OCT Intravascular Imaging Sys-
tem, St. Jude Medical, St. Paul, Minnesota) were used
in the study. In brief, with the M2/M3 system, an
occlusion balloon (Helios, LightLab Imaging Inc.,
Westford, Massachusetts) was advanced proximal to
the lesion and inﬂated #0.7 atm, and saline was
infused into the coronary artery from the distal tip of
the occlusion balloon catheter during image acquisi-
tion. The M2/M3 OCT wire was automatically pulled
back from distal to proximal at 1.0 to 3.0 mm/s. With
the C7-XR system, a 2.7-F OCT imaging catheter
(Dragonﬂy, St. Jude Medical) was advanced distal to
TABLE 1 Patient Characteristics (n ¼ 255)
Age, yrs 59.9  10.8
Male 190 (75)
Smoking 86 (34)
Diabetes mellitus 105 (41)
Hypertension 169 (66)
Hyperlipidemia 171 (67)
Prior MI 67 (26)
PAD 9 (4)
Prior PCI 62 (24)
Indication for angiography
STEMI 31 (12)
NSTE-ACS 120 (47)
Stable angina 104 (41)
Laboratory ﬁndings
TC, mg/dl 178  50
HDL-C, mg/dl 46  15
LDL-C, mg/dl 93  33
TG, mg/dl 145 (89, 212)
HbA1C, % 6.3  1.4
hs-CRP, mg/dl 0.20 (0.10, 0.50)
Values are mean  SD, n (%), or median (25th, 75th percentiles).
HbA1c ¼ glycated hemoglobin; HDL-C ¼ high-density lipoprotein cholesterol;
hs-CRP ¼ high-sensitivity C-reactive protein; LDL-C ¼ low-density lipoprotein
cholesterol; MI ¼ myocardial infarction; NSTE-ACS ¼ non–ST-segment elevation
acute coronary syndrome; PAD ¼ peripheral artery disease; PCI ¼ percutaneous
coronary intervention; STEMI ¼ ST-segment elevation myocardial infarction; TC ¼
total cholesterol; TG ¼ triglyceride.
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674the lesion, and automatic pullback was started as
soon as the blood was cleared.
OCT ANALYSIS. The 2 experienced investigators at
the MGH OCT core laboratory analyzed the OCT im-
ages using proprietary software (St. Jude Medical). In
case of discordance between the reviewers, a third
reader was involved to reach a consensus on image
matching and quality. To be considered as 2 separate
plaques in the same vessel, the segment between
them had to be >5 mm. If not, they were considered
1 long lesion. Fibrous cap thickness was measured
at its thinnest part 3 times, the average value was
calculated, and the minimum values of ﬁbrous cap
thickness in each plaque were selected. Lipid arc was
measured at every 1-mm interval throughout the
entire lesion. A TCFA was deﬁned as a plaque with
ﬁbrous cap thickness <65 mm overlying a lipid-rich
plaque (maximum lipid arc >90) (2,8,9).
All TCFA lesions were further evaluated. Lipid
length was measured on the longitudinal view. A
microvessel was characterized by a black hole within a
plaquewith a diameter of 50 to 300 mmthatwas seen on
at least 3 consecutive frames (2,8–10). Macrophage
accumulation on the lesion was characterized by
increased signal intensity within the lesion, accom-
panied by heterogeneous backward shadows (2).
Presence of cholesterol crystals was characterized by
the presence of linear and highly-reﬂecting structures
within lesions. Calciﬁcation is an area with low back-
scatter signal and a sharp border (2,8,9).
IVUS ANALYSIS. The corresponding IVUS images of
OCT-derived TCFA were selected using ﬁduciary
points, such as calciﬁcations, side branches, and/or
stents. Two independent reviewers at the MGH core
laboratory using EchoPlaque (Indec Systems, Moun-
tain View, California) analyzed the IVUS images.
Quantitative IVUS parameters included the external
elastic membrane (EEM), the lumen cross-sectional
area (CSA), the maximum atheroma diameter and the
minimum atheroma diameter, and the plaque plus
media (PþM) CSA. The plaque eccentricity index was
calculated as: (maximum atheroma diameter  mini-
mum atheroma diameter)/maximum atheroma diam-
eter. The plaque burden was calculated as: (PþMCSA)/
(EEM CSA)100. The reference was the frame showing
the largest lumen area within 10 mm proximal and
distal from the target lesions. The remodeling index
was calculated as: (EEM CSA at theMLA slice)/(average
of the proximal and distal reference EEM CSA).
DEFINITION OF RISK FACTORS. Diabetes mellitus
was diagnosed if a patient met 1 of the following
criteria: documented history of diabetes mellitus, use
of hypoglycemic agents, fasting glucose $126 mg/dl,2-h plasma glucose level $200 mg/dl in the oral
glucose tolerance test, classic symptom with casual
plasma glucose level $200 mg/dl, or glycated
hemoglobin $6.5%. Hypertension was deﬁned as a
systolic blood pressure >140 mm Hg, diastolic blood
pressure >90 mm Hg, or antihypertensive therapy
received at the time of the imaging. Hyperlipidemia
was diagnosed in those with a history of hyperlipid-
emia, receiving lipid-lowering treatment, or newly
diagnosed with hyperlipidemia (total serum choles-
terol >240 mg/dl).
STATISTICAL ANALYSIS. Statistical analysis was
performed with SPSS version 17.0 (SPSS Inc., Chicago,
Illinois). Categorical data were presented as counts
and proportions. Continuous variables were ex-
pressed as mean  SD for normally distributed vari-
ables and as medians (25th to 75th percentiles) for
non-normally distributed variables, as appropriate.
On the basis of the angiographic diameter stenosis,
all lesions were divided into 3 groups: Group A (30%
to 49%), Group B (50% to 69%), and Group C (>70%).
Angiographic, OCT, and IVUS ﬁndings of TCFA in
each group were compared. Comparisons of patient
and morphological characteristics among the 3
groups were carried out by means of the generalized
estimating equations approach to take into account
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FIGURE 1 Correlation Between the Absolute Number and
Relative Prevalence of TCFA and Degree of Stenosis
(A) Among the 643 lesions, 325 plaques had mild stenosis,
227 had moderate stenosis, and 91 had severe stenosis. (B) The
absolute number of thin-cap ﬁbroatheromas (TCFAs) was greater
in plaques with mild to moderate stenosis compared with those
with severe stenosis. (C) The relative prevalence of TCFA was
signiﬁcantly higher in Group C than in Groups A or B.
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675the multiple plaques identiﬁed from the same pa-
tient. Logarithmic transformation was performed
for the non-normally distributed variables. For the
multiple comparisons among the 3 groups, Bonfer-
roni’s correction was applied, thus a p < 0.017 was
considered statistically signiﬁcant.
RESULTS
CLINICAL CHARACTERISTICS. A total of 255 patients
were included in this study. The patients’ clinical
characteristics are summarized in Table 1. In these
255 subjects, 643 plaques with >30% angiographic
diameter stenosis were detected. Of 643 lesions, 325
(51%) had 30% to 49% diameter stenosis (Group A),
227 (35%) had 50% to 69% diameter stenosis (Group B),
and 91 (14%) had >70% diameter stenosis (Group C)
(Fig. 1A).
ABSOLUTE AND RELATIVE NUMBER OF TCFA IN
EACH GROUP. Among 643 lesions, the number of
TCFA was 58 of 325 in Group A, 40 of 227 in Group B,
and 33 of 91 in Group C (Fig. 1B). Therefore, the
prevalence of TCFA was twice as high among severe
lesions compared with mild or moderate lesions: 36%
in Group C, 18% in Group A, and 18% in Group B
(p ¼ 0.003 and p ¼ 0.002, respectively) (Fig. 1C). A
representative case with TCFA and a severe stenosis
is shown in Figure 2.
CLINICAL CHARACTERISTICS OF TCFA. The clinical
characteristics of patients with TCFA in each group
are presented in Table 2. Group C had a signiﬁcantly
higher glycated hemoglobin level compared with
Group A (p ¼ 0.006). There were no statistically sig-
niﬁcant differences in other variables among the 3
groups.
IMAGING FINDINGS OF TCFA. The angiography data
of all TCFA in each group are presented in Table 3. No
signiﬁcant difference was seen in reference vessel
diameter or in the distribution of plaques among the
3 groups.
The mean length of coronary arteries imaged by
OCT was 76  23 mm in the left anterior descending
coronary artery, 49  17 mm in the left circumﬂex
artery, and 96  26 mm in the right coronary artery.
OCT ﬁndings of all TCFA are shown in Table 4.
Fibrous cap thickness of TCFA was thinner in Group
C compared with Groups A (p < 0.001) or B (p ¼
0.001). There were no signiﬁcant differences among
the 3 groups in lipid arc and lipid length. As
compared with Group A, microvessel and choles-
terol crystal within TCFA were more frequent in
Group C (p < 0.001 and p ¼ 0.002, respectively).
The prevalence of macrophage accumulation andcalciﬁcation were not statistically different among
the 3 groups.
The mean length of coronary arteries imaged by
IVUS was 83  18 mm in the left anterior descending
coronary artery, 71  19 mm in the left circumﬂex
artery, and 87  26 mm in the right coronary artery.
IVUS ﬁndings are presented in Table 5. TCFA in
Group C had smaller lumen CSA, larger PþM CSA,
and higher remodeling index compared with those
in Group A (p < 0.001, p ¼ 0.001, and p ¼ 0.002,
respectively). The plaque burden was largest in the
TCFA of Group C (80.1  7.4%), followed by those in
Groups B (67.5  9.4%) and A (58.1  8.4%). Plaque
eccentricity of TCFA was greater in Group C than
in Groups A (p < 0.001) or B (p ¼ 0.009).
EEM CSA at the proximal and distal reference
segments was similar among the 3 groups. Lumen
FIGURE 2 Representative Case of TCFA
This case demonstrates a ruptured thin-cap ﬁbroatheroma (TCFA) at the tight stenosis in the left anterior descending artery (LAD) as well as
nonruptured TCFA at a severe lesion in the distal right coronary artery (RCA) in the same patient. Angiogram (A) shows a culprit lesion in the
proximal LAD. In the same patient, a severe nonculprit lesion was found in the distal RCA (B). Red lines on A and B indicate the location where
the optical coherence tomography (OCT) images were obtained. OCT images of the culprit lesion show plaque rupture (white arrows) (C) and
TCFA (red arrows) (D). In the nonculprit lesion with severe stenosis in the distal RCA, TCFA was identiﬁed (yellow arrows) (E and F).
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676CSA at the distal reference site was signiﬁcantly
smaller in Group C than in Group A (p < 0.001).
DISCUSSION
To the best of our knowledge, this is the ﬁrst in vivo
study investigating the absolute number, relative
prevalence, and characteristics of TCFA in relation to
angiographic luminal narrowing using 3 imaging
modalities. In this study, because the total number
of plaques with mild to moderate stenosis is large,
the absolute number of TCFA in this population was
3 times higher than in those with severe stenosis
(Central Illustration). However, the prevalence of
TCFA was twice as high in those plaques with severe
angiographic stenosis >70% compared with those
with mild or moderate stenosis. Moreover, TCFA in
patients with severe lesions had greater plaque
burden and more features of vulnerability, including
microvessels, cholesterol crystal, thinner ﬁbrous cap,
and higher vessel remodeling index.TCFA AT THE SITE OF SEVERE STENOSIS. TCFA is
considered to be an in vivo equivalent of vulnerable
plaque. The current study showed that prevalence
of TCFA was higher in severely-stenotic lesions than
in mild to moderate stenosis. A recent virtual his-
tology IVUS study also reported that the frequency
of TCFA increases with increasing angiographic dia-
meter stenosis of the lesion (11). Moreover, TCFA in
severely-stenotic areas had more features of plaque
vulnerability.
The ﬁbrous cap thickness is a major determinant in
the vulnerability of atherosclerotic lesions to rupture
(12). Although thin ﬁbrous cap (<65 mm) deﬁned by
pathological study has been recognized as the most
critical feature of TCFA, the ﬁbrous cap thickness has
been reported to be signiﬁcantly different between
ruptured plaque and nonruptured TCFA (12,13). A
histology study from Narula et al. (12) has demon-
strated that the best morphological characteristic to
differentiate the ruptured plaque from TCFA was
ﬁbrous cap thickness <54 mm, suggesting that ﬁbrous
TABLE 2 Clinical Characteristics of TCFA in the 3 Groups
Group A
(n ¼ 58)
Group B
(n ¼ 40)
Group C
(n ¼ 33)
p Value
A vs. B
p Value
A vs. C
p Value
B vs. C
Age, yrs 58.6  11.2 60.1  9.2 59.3  12.1 0.423 0.770 0.763
Male 43 (74) 29 (73) 20 (61) 0.874 0.228 0.253
Smoking 21 (36) 12 (30) 15 (46) 0.548 0.393 0.182
Diabetes mellitus 25 (43) 19 (48) 18 (55) 0.699 0.305 0.550
Hypertension 30 (52) 25 (63) 23 (70) 0.349 0.109 0.548
Hyperlipidemia 36 (62) 26 (65) 20 (61) 0.790 0.895 0.679
Prior MI 14 (24) 9 (23) 5 (15) 0.871 0.319 0.445
PAD 1 (2) 1 (3) 4 (12) 0.101 0.022 0.062
Prior PCI 11 (19) 7 (18) 4 (12) 0.862 0.405 0.446
Indication for angiography
STEMI 10 (17) 5 (13) 8 (24) 0.479 0.456 0.253
NSTE-ACS 34 (59) 25 (63) 22 (67) 0.716 0.467 0.713
Stable angina 14 (24) 10 (25) 3 (9) 0.928 0.071 0.049
Laboratory ﬁndings
TC, mg/dl 191  55 184  43 194  54 0.567 0.756 0.409
HDL-C, mg/dl 50  18 50  26 50  15 0.959 0.929 0.995
LDL-C, mg/dl 101  35 107  32 97  31 0.397 0.585 0.191
TG, mg/dl 158 (105, 206) 177 (121, 271) 195 (118, 252) 0.397 0.260 0.936
HbA1C, % 6.3  1.1 6.6  1.4 7.7  2.5 0.406 0.006 0.038
hs-CRP, mg/dl 0.20 (0.10, 0.44) 0.12 (0.10, 0.59) 0.28 (0.10, 1.06) 0.442 0.340 0.759
Values are mean  SD, n (%), or median (25th, 75th percentiles). p < 0.017 was considered signiﬁcant.
TCFA ¼ thin-cap ﬁbroatheroma; other abbreviations as in Table 1.
TABLE 3 Angiographic Findings of TCFA
Group A
(n ¼ 58)
Group B
(n ¼ 40)
Group C
(n ¼ 33)
p Value
A vs. B
p Value
A vs. C
p Value
B vs. C
MLD, mm 2.08  0.47 1.44  0.42 0.78  0.22 <0.001 <0.001 <0.001
DS, % 40.0  6.0 57.0  6.0 76.0  4.8 <0.001 <0.001 <0.001
RD, mm 3.45  0.63 3.33  0.71 3.23  0.69 0.416 0.049 0.253
Lesion location
LAD 15 (26) 17 (43) 15 (46) 0.077 0.040 0.825
RCA 34 (59) 11 (28) 14 (42) 0.002 0.137 0.196
LCX 9 (16) 12 (30) 4 (12) 0.095 0.654 0.079
Values are mean  SD or n (%). p < 0.017 was considered signiﬁcant.
DS ¼ diameter stenosis; LAD ¼ left anterior descending coronary artery; LCX ¼ left circumﬂex artery; MLD ¼
minimum lumen diameter; RCA ¼ right coronary artery; RD ¼ reference diameter; RVD ¼ reference vessel
diameter; TCFA ¼ thin-cap ﬁbroatheroma.
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Interestingly, the mean thickness of ﬁbrous cap in
TCFA with severe stenosis (49  9.2 mm) was below
this threshold in this study. Therefore, TCFA at
severely-stenotic areas with thinner ﬁbrous cap may
make it more susceptible to rupture.
The current study also showed that severely-
stenotic TCFA had a larger plaque burden and
higher remodeling index. Histology studies have
conﬁrmed that plaque rupture, in combination with a
severe pre-existing luminal narrowing, is a milieu
that puts patients at a very high risk for occlusive
thrombus formation and occurrence of the fatal acute
myocardial infarction (12,14,15). Clinical studies using
angiography (16), IVUS (17), and angioscopy (18) have
conﬁrmed that multiple plaque ruptures were com-
mon in patients with ACS. However, symptomatic
rupture had a smaller lumen area, greater plaque
burden, and more positive remodeling (17). Some
prospective IVUS studies have conﬁrmed that TCFA
with >70% of plaque burden were more likely to
develop recurrent clinical events during follow-up
(3,4). It is conceivable that the thrombus formation
following a ruptured TCFA with severe stenosis is
more likely to further limit the blood ﬂow leading to
clinical events.
Additionally, we observed more frequent micro-
vessels and cholesterol crystals in severely-stenoticTCFA in the present study. OCT has been widely
used to visualize microstructures within plaques,
including macrophage accumulation, microvessels,
and cholesterol crystals (2,8–10,19). The intraplaque
microvessel detected by OCT has been reported to
be a feature of plaque vulnerability (8,10) and a pre-
dictive marker for plaque progression (2).
The role of coronary stenosis severity in the
development of acutemyocardial infarction is debated
(20). On the basis of our ﬁndings, it is reasonable to
speculate that patients with severely-stenotic lesions
are at increased risk of cardiovascular adverse events
TABLE 4 OCT Findings of TCFA
Group A
(n ¼ 58)
Group B
(n ¼ 40)
Group C
(n ¼ 33)
p Value
A vs. B
p Value
A vs. C
p Value
B vs. C
FCT, mm 57.0  6.6 56.0  7.5 49.0  9.2 0.762 <0.001 0.001
Lipid arc,  214  56 209  55 204  59 0.669 0.837 0.766
Lipid length, mm 9.4  4.6 10.5  5.5 9.6  4.5 0.218 0.846 0.393
Microvessel 13 (22) 15 (38) 19 (58) 0.141 <0.001 0.082
Cholesterol crystal 8 (14) 10 (25) 13 (40) 0.048 0.002 0.429
Macrophage 44 (76) 29 (73) 28 (85) 0.749 0.215 0.234
Calciﬁcation 25 (43) 18 (45) 14 (42) 0.793 0.958 0.880
Values are mean  SD or n (%). p < 0.017 was considered signiﬁcant.
FCT ¼ ﬁbrous cap thickness; OCT ¼ optical coherence tomography; TCFA ¼ thin-cap ﬁbroatheroma.
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678in the near future and are in need of more aggressive
treatment. Supporting this notion, an angiographic
study from Zaman et al. (21) had reported that high-
grade coronary stenosis was an important predictor
of acute coronary events in subsequent months. At
the onset of acute myocardial infarction, most culprit
lesions are found to have severe stenosis (22,23); this
also suggests that severe lumen narrowing appears
to be an important pre-condition for vulnerable pla-
ques, resulting in acute coronary events. Frøbert
et al. (22) have reported that >90% of patients with
acute myocardial infarction presented with a stenosis
severity >50%, and >60% presented with a stenosis
severity >70%. Another study by Manoharan et al.
(23) has demonstrated that only 10% of lesions in
patients with acute myocardial infarction had diam-
eter stenosis <50% after successful aspiration of
thrombus.
TCFA AT THE SITE OF MILD TO MODERATE STENOSIS.
Another important ﬁnding of the current study is thatTABLE 5 IVUS Findings of TCFA
Group A
(n ¼ 36)
Group B
(n ¼ 25)
Lesion site
Lumen CSA, mm2 5.8  2.4 4.5  2.1
PþM CSA, mm2 7.7  2.3 9.8  4.3
Remodeling index 0.98  0.10 1.02  0.13
Plaque burden, % 58.1  8.4 67.5  9.4
Plaque eccentricity 0.77  0.11 0.79  0.14
EEM CSA, mm2 13.5  4.3 14.4  5.3
Proximal reference site, mm2
EEM CSA 14.3  4.3 14.7  5.7
Lumen CSA 8.4  2.8 8.4  4.1
Distal reference site, mm2
EEM CSA 13.2  4.5 13.7  5.5
Lumen CSA 8.4  3.2 7.3  2.8
Values are mean  SD. p < 0.017 was considered signiﬁcant.
CSA ¼ cross-sectional area; EEM ¼ external elastic membrane; IVUS ¼ intravascular uthe absolute number of TCFA in nonseverely-stenotic
lesions was 3 times higher than in severely-stenotic
lesions due to a greater total number of plaques
with mild to moderate stenosis. TCFA at mild to
moderate stenosis may not cause clinical events
during a short-term follow-up, but it may lead to an
adverse event during long-term follow-up when the
luminal narrowing reaches a critical level. In the
current study, nonseverely-stenotic lesions had
smaller plaque burden and larger lumen area com-
pared with severely-stenotic lesions. A study by
Cheng et al. (4) has demonstrated that TCFA with
large plaque burden were related to higher short-
and long-term clinical events, whereas TCFAs with
small plaque burden were related to long-term
clinical events (4). A greater number of TCFAs at
nonseverely-stenotic sites may explain the ﬁndings,
obtained from several previous studies with long in-
tervals between baseline and follow-up, that acute
coronary events commonly arise from nonseverely-
stenotic lesions (24–26). It is important to note that
most patients in the previous studies had an ST-
segment elevation myocardial infarction (24–26),
whereas the majority of our patients were undergo-
ing angiography for non–ST-segment elevation ACS
or stable angina.
STUDY LIMITATIONS. First, this study is retrospec-
tive and descriptive in nature, making selection bias
unavoidable. Second, we selected the patients who
underwent 3-vessel OCT imaging to minimize the
potential bias; however, the decision to perform
3-vessel OCT was at the discretion of the operator.
Third, the deﬁnition of OCT-derived TCFA is some-
what different from the histological deﬁnition ofGroup C
(n ¼ 14)
p Value
A vs. B
p Value
A vs. C
p Value
B vs. C
3.2  2.3 0.031 <0.001 0.055
11.8  4.4 0.026 0.001 0.145
1.09  0.13 0.225 0.002 0.045
80.1  7.4 <0.001 <0.001 <0.001
0.88  0.07 0.435 <0.001 0.009
14.9  6.3 0.489 0.390 0.736
14.2  6.3 0.709 0.925 0.752
6.8  3.6 0.976 0.551 0.169
13.3  5.2 0.652 0.954 0.793
6.1  3.1 0.187 <0.001 0.170
ltrasound; PþM ¼ plaque plus media; TCFA ¼ thin-cap ﬁbroatheroma.
CENTRAL ILLUSTRATION Plaque Vulnerability and Coronary Artery Stenosis
The absolute number of plaque and thin-cap ﬁbroatheroma (TCFA) is greater in the area
with mild stenosis. The relative prevalence of TCFA increases as the degree of coronary
artery stenosis increases. Furthermore, TCFA at a higher degree of stenosis has more
features of plaque vulnerability.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Severely-
stenotic coronary atherosclerotic lesions are associated with a
higher risk of plaque rupture than less-stenotic lesions.
TRANSLATIONAL OUTLOOK: Additional research is needed
to deﬁne optimal therapeutic strategies for patients with
severely-stenotic high-risk atherosclerotic lesions.
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679TCFA due to the inability of OCT to determine the
size of the necrotic core. Fourth, although OCT im-
aging was performed in 3 vessels, the very proximal
segment was not visualized because of the proximal
occlusion balloon when the time-domain OCT system
was used. Fifth, both frequency- and time-domain
OCT systems were used in the present study,
although the percentages of imaged plaques by each
modality were similar between the 3 groups. Sixth,
the number of TCFAs in the Group C was relatively
small. Seventh, a lack of longitudinal follow-up did
not allow assessment of the clinical signiﬁcance of
TCFA. In addition, macrophage, microvessels, and
cholesterol crystals on OCT have not been vigorously
validated. Finally, IVUS was used only in a subset
of patients.
CONCLUSIONS
The absolute number of TCFA is 3 times greater in
nonsevere stenosis than in severe stenosis. It is,
however, twice as likely for a lesion to be a TCFA in a
severe stenosis as in a nonsevere stenosis. Further-
more, severely-stenotic TCFA has more features of
plaque vulnerability and greater plaque burden.
These ﬁndings suggest that severely-stenotic TCFA
lesions may lead to clinical events in the near future,
whereas a greater number of mild to moderate le-
sions may lead to adverse events during long-term
follow-up.
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